Cover Image
市場調查報告書

皮膚癌:全球臨床實驗檢討

Skin Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 304741
出版日期 內容資訊 英文 214 Pages
訂單完成後即時交付
價格
Back to Top
皮膚癌:全球臨床實驗檢討 Skin Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月26日 內容資訊: 英文 214 Pages
簡介

本報告提供皮膚癌相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,並彙整臨床實驗的主要國家,G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,地區、PHASE、階段別的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

目錄

簡介

  • 皮膚癌
  • 本報告概要

各地區的臨床實驗情形

各國臨床實驗數量和平均實驗人數

  • 亞太地區前五名國家的臨床實驗數量
  • 歐洲前五名國家的臨床實驗數量
  • 北美主要國家的臨床實驗數量
  • 中東及非洲主要國家的臨床實驗數量
  • 中南美前五名國家的臨床實驗數量

G7各國臨床實驗數量:癌症臨床實驗數量中,皮膚癌的比率

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7(新興7個國家)的臨床實驗數量:癌症臨床實驗數量中,皮膚癌的比率

E7(新興7個國家)臨床實驗數量:Phase別

E7(新興7個國家)臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

最新臨床實驗資訊

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Bristol-Myers Squibb Company
    • Novartis AG
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Pfizer Inc.
    • AstraZeneca PLC
    • Eisai
    • Bayer AG
    • Celgene Corporation
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • The University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • European Organization for Research and Treatment of Cancer
    • University of Virginia
    • Mayo Clinic
    • University of Pittsburgh
    • Roswell Park Cancer Institute
    • Eastern Cooperative Oncology Group

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2161CTIDB

GlobalData's clinical trial report, "Skin Cancer Global Clinical Trials Review, H1, 2014" provides data on the Skin Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Skin Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Skin Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Skin Cancer
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Skin Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Skin Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Skin Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Skin Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Skin Cancer
    • Jan 27, 2014: Immune Design Announces Treatment of First Patient in Phase 1 Clinical Trial of ID-G100, an Investigational Immuno-Oncology Agent
    • Dec 19, 2013: Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100
    • Nov 06, 2013: Aclaris Therapeutics Initiates IND-Directed Program for A-101 for the Treatment of Seborrheic Keratosis, Common Type of Skin Tumor
    • Feb 11, 2013: Gefitinib Shows Promise in Treating Skin Cancer, Study Finds
    • Jan 30, 2013: Silibinin Protects Against UV-induced Skin Cancer, Researchers Report
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • University of Virginia
      • Clinical Trial Overview of University of Virginia
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Skin Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Skin Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Skin Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Skin Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Skin Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Skin Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Skin Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Skin Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014*
  • Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014*

List of Figures

  • Skin Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Skin Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Skin Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Skin Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Skin Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Skin Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Skin Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Skin Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Skin Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Skin Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Skin Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top